To assess the predictive significance of invasive FoxP3+ Tregs in patients with various subtypes of biliary tract cancer, a subgroup analysis was conducted specifically focusing on gallbladder carcinoma and cholangiocarcinoma (including intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma). The gene discussed is FOXP3; the disease is gallbladder carcinoma.